GlassScriptPhysician profile
Ellen T Haas
NPI 1124256854
$11,042.14
in general payments reported to CMS, 2019-2025
35 companies · $776 in 2025
The $776 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,980 · 2020: $1,576 · 2021: $3,060 · 2022: $2,238 · 2023: $487 · 2024: $925 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,078 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,078.39 |
| Education | $110.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $2,879.41 | 2019-2020 | |
| Organon LLC | $2,860.39 | 2021-2025 | Nexplanon |
| Coloplast Corp | $1,424.74 | 2021-2024 | Saffron |
| Abbvie INC. | $943.58 | 2019-2025 | |
| Astellas Pharma US INC | $491.55 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $488.08 | 2023-2025 | Gemtesa, Myfembree |
| Therapeuticsmd, INC. | $311.15 | 2019-2022 | |
| Biogen, INC. | $215.08 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $212.05 | 2021-2025 | |
| Gynesonics, INC. | $192.20 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $147.69 | 2019-2025 | |
| Daiichi Sankyo INC. | $81.66 | 2022-2023 | Injectafer |
| Coopersurgical, INC. | $80.83 | 2019-2024 | Advincula Delineator Uterine Manipulator |
| Hologic Sales and Service, LLC | $72.60 | 2019-2024 | Affirm Prone Biopsy System, Aptima |
| Lilly USA, LLC | $54.81 | 2025 | Zepbound |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $53.92 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $50.73 | 2019 | |
| Exeltis, USA INC. | $44.45 | 2024-2025 | Slynd |
| Mayne Pharma Commercial LLC | $44.41 | 2025 | |
| Exact Sciences Corporation | $43.19 | 2023-2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $40.58 | 2022-2024 | Auvelity |
| Myovant Sciences INC. | $37.59 | 2022 | |
| Lupin INC. | $37.29 | 2019-2020 | |
| Evofem Biosciences, INC. | $35.18 | 2021-2022 | |
| Scynexis, INC. | $25.93 | 2022 | |
| Heron Therapeutics, INC. | $23.66 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $22.39 | 2025 | |
| Novo Nordisk INC | $20.70 | 2024 | Wegovy |
| Conmed Corporation | $18.73 | 2024 | Vcare, Airseal |
| Axonics, INC. | $17.69 | 2020 | |
| Davol INC. | $16.02 | 2022 | |
| Roche Diagnostics Corporation | $15.14 | 2019 | |
| Olympus America INC. | $13.51 | 2021 | |
| Radius Health, INC. | $13.16 | 2019 | |
| Convatec INC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.